venetoclax

Research Reports

The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences

06/21/2022

Matthew S. Davids , MD, MMSc;

Mazyar Shadman , MD, MPH;

Beenish S. Manzoor , PhD, MPH;

Kavita Sail , PhD;

Arliene Ravelo , MPH;

Fang Han ;

Sheila Shapouri , MS;

Nisha C. Hazra , PhD, MSc;

Annie Guerin , MS;

Honghao Fang , MSc;

Dr Davids and colleagues estimated the total cumulative costs per patient of treatment sequences for adults with chronic lymphocytic leukemia, with and without deletion 17p, as well as the budget impact of introducing sequences with...

Dr Davids and colleagues...

06/21/2022

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

venetoclax

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products